KALA BIO(GB:0JQ2)
$0.17-0.00 (-1.16%)
GB:0JQ2
KALA BIO financials statements
$0.17
At close:-0.00 (-1.16%)
KALA BIO (0JQ2) Financial Statements
0 Followers
KALA BIO Financial Overview
KALA BIO's market cap is currently $3.31M. The company's EPS TTM is $-81.82; its P/E ratio is -0.00; and it has a dividend yield of 0.34%. KALA BIO has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Mar 25 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 3.89M | $ 11.24M |
| Gross Profit | $ 0.00 | $ -259.00K | $ -303.00K | $ 1.33M | $ 7.14M |
| Operating Income | $ -39.16M | $ -40.43M | $ -39.15M | $ -81.36M | $ -109.43M |
| EBITDA | $ -23.39M | $ -32.47M | $ -36.08M | $ -37.02M | $ -133.25M |
| Net Income | $ -26.98M | $ -38.51M | $ -42.20M | $ -44.82M | $ -142.60M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 7.56M | $ 51.18M | $ 50.90M | $ 70.50M | $ 92.14M |
| Total Assets | $ 9.49M | $ 55.48M | $ 55.95M | $ 86.82M | $ 139.43M |
| Total Debt | $ 0.00 | $ 32.25M | $ 36.32M | $ 42.95M | $ 80.19M |
| Net Debt | $ -7.56M | $ -18.93M | $ -14.57M | $ -27.55M | $ -11.95M |
| Total Liabilities | $ 2.49M | $ 43.15M | $ 48.45M | $ 67.85M | $ 122.62M |
| Stockholders' Equity | $ 7.00M | $ 12.33M | $ 7.50M | $ 18.97M | $ 16.80M |
| Cash Flow | |||||
| Free Cash Flow | $ -31.99M | $ -29.59M | $ -28.54M | $ -79.22M | $ -109.12M |
| Operating Cash Flow | $ -31.99M | $ -29.38M | $ -27.93M | $ -78.91M | $ -108.23M |
| Investing Cash Flow | $ -15.00K | $ -208.00K | $ -429.00K | $ 62.72M | $ 70.80M |
| Financing Cash Flow | $ -11.62M | $ 29.88M | $ 8.51M | $ -7.94M | $ 42.55M |
Currency in USD
